# A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer

> **NCT00159094** · PHASE2 · UNKNOWN · sponsor: **Hematology Oncology Consultants** · enrollment: 30 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Doxil and Vinorelbine

## Key facts

- **NCT ID:** NCT00159094
- **Lead sponsor:** Hematology Oncology Consultants
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00159094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00159094, "A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00159094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*